Compare Ascendis Pharma A/S (ASND) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Hims and Hers Health Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Hims and Hers Health Inc trades at $30.65 (market cap $7.12B). The key difference: Ascendis Pharma A/S is far larger — about 2.3× Hims and Hers Health Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| ASND | HIMS | |
|---|---|---|
Market Cap | $16.67B | $7.12B |
Sector | Health | Health |
52-Week High | $277.18 | $62.76 |
52-Week Low | $189.74 | $14.52 |
Enterprise Value | $17.04B | $7.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
